Prescribing pre-exposure prophylaxis in general practice

Pre-exposure Prophylaxis (PrEP)

In 2012, the US Food and Drug Administration (FDA) approved Truvada to be used as PrEP by HIV negative people who are at high risk of sexually acquired HIV infection. The US Centre for Disease Control has since developed guidelines and recommended PrEP be used by people at high risk of HIV acquisition via sexual transmission or injection drug use (http://www.cdc.gov/hiv/prevention/research/prep/).

post-exposure prophylaxis: knowledge and practice among general dental practitioners in hamadan, iran

conclusions this study revealed a low level of knowledge and practice regarding post-exposure prophylaxis, with the mean score of some respondents being below 50%. objectives this study was conducted with the aim of demonstrating the level of knowledge and practice amongst general dental practitioners in hamadan city, iran in 2013 - 14, in terms of prevention after dealing with blood-borne path...

Annotated Bibliography: Pre-Exposure Prophylaxis

Promoting Rational Drug Prescribing in General Practice

Vægter, K. 2013. Promoting Rational Drug Prescribing in General Practice. Acta Universitatis Upsaliensis. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 858. 64 pp. Uppsala. ISBN 978-91-554-8582-5. Aims: To introduce the concepts “quality assurance”, “rational drug prescribing” and “outreach visits” in general practice in Storstrøm County, Denmark and stud...

Pre-exposure rabies prophylaxis: a systematic review

OBJECTIVE To review the safety and immunogenicity of pre-exposure rabies prophylaxis (including accelerated schedules, co-administration with other vaccines and booster doses), its cost-effectiveness and recommendations for use, particularly in high-risk settings. METHODS We searched the PubMed, Centre for Agriculture and Biosciences International, Cochrane Library and Web of Science database...